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1Abstract
Background 
The 4-variable Modification of Diet in Renal Disease (4-v MDRD) and Cockcroft-Gault (CG) 
equations are commonly used for estimating glomerular filtration rate (GFR); however,
neither of these equations has been validated in an indigenous African population. The aim of 
this study was to evaluate the performance of the 4-v MDRD and CG equations for 
estimating GFR in black South Africans against measured GFR and to assess the 
appropriateness for the local population of the ethnicity factor established for African 
Americans in the 4-v MDRD equation.
Methods
We enrolled 100 patients in the study. The plasma clearance of chromium-51–EDTA (51Cr-
EDTA) was used to measure GFR, and serum creatinine was measured using an isotope 
dilution mass spectrometry (IDMS) traceable assay. We estimated GFR using both the 
reexpressed 4-v MDRD and CG equations and compared it to measured GFR using 4
modalities: correlation coefficient, weighted Deming regression analysis, percentage bias,
and proportion of estimated GFR within 30% of measured GFR (P30).
Results
The Spearman correlation coefficient between measured and estimated GFR for both 
equations was similar (4-v MDRD R2 = 0.80 and CG R2 = 0.79). Using the 4-v MDRD 
equation with the ethnicity factor of 1.212 as established for African Americans resulted in a 
median positive bias of 13.1 (95% CI 5.5 to 18.3) mL/min/1.73m2. Without the ethnicity 
factor median bias was 1.9 (95% CI -0.8 to 4.5) mL/min/1.73m2.
2Conclusion
The 4-v MDRD equation, without the ethnicity factor of 1.212, can be used for estimating 
GFR in black South Africans. 
3Introduction
Globally chronic kidney disease (CKD) is recognized as an important public health problem 
(1). In South Africa (SA) the high prevalence of hypertension, diabetes mellitus and infection 
with human immunodeficiency virus (HIV) results in a significant risk for CKD (2). It is 
therefore important to detect kidney dysfunction as early as possible in this population. 
Current guidelines define CKD as the presence, for three or more months, of either kidney 
damage as defined by structural or functional abnormalities of the kidney or a GFR < 60 
mL/min/1.73m2 (3, 4). GFR is an important component in the diagnosis of CKD and is also 
accepted as the best overall measure of kidney function (3, 5). Individuals with decreased 
GFR are not only at increased risk for the development of end stage renal failure (ESRD) but 
are also at increased risk for hospitalizations, cardiovascular disease (CVD) and other 
complications of decreased kidney function (6-10). It has been shown that early detection, 
appropriate evaluation and management of CKD improves outcome (1, 3, 4).
GFR can be measured as the renal clearance of exogenous markers such as Inulin, 
51Chromium ethylenediaminetetraacetic acid (51Cr-EDTA), technetium-labeled diethylene-
triamine-pentacetate (99mTc-DTPA) and Iohexol. However these exogenous markers are 
impractical for routine use. Endogenous GFR markers include creatinine and cystatin C. 
Creatinine is the most commonly used marker in the clinical laboratory to assess GFR, 
however it has multiple limitations (11). For example creatinine concentration is not only 
determined by GFR but is also affected by factors such as muscle mass, diet, gender and age 
(12, 13). 
To overcome some of these limitations the National Kidney Foundation-Kidney Disease 
Outcomes Quality Initiative (NKF-K/DOQI) and Kidney Disease: Improving Global 
4Outcomes (KDIGO) guidelines recommend the estimation of GFR (eGFR) using prediction 
equations based on serum creatinine (S-Cr) (3, 4). The two most commonly used prediction 
equations are the 4 variable Modification of Diet in Renal Disease (4-v MDRD) (14) and 
Cockcroft-Gault (CG) equation (15). The MDRD equation was derived in the United States 
from data from 1628 patients with known kidney-disease (651 women and 195 African-
Americans) using 125I-iothalamate clearance to measure GFR as the reference procedure 
(mean GFR 40 mL/min/1.73m2) and was based on 6 variables: age, sex, serum creatinine, 
urea, albumin and ethnicity (16). Subsequently a 4-v MDRD equation, based on 4 variables: 
age, sex, serum creatinine and ethnicity was proposed to simplify its use in the clinical 
environment (14). An ethnicity factor of 1.212 was established for African Americans (14, 
16). 
Because of variability in serum creatinine assays the National Kidney Disease Education 
Program (NKDEP) Laboratory Working Group initiated a creatinine standardization program 
with creatinine calibration traceable to isotope dilution mass spectrometry (IDMS) creatinine 
measurement (17). The 4-v MDRD equation was re-expressed for use with the IDMS 
traceable creatinine measurements (18). 
The Cockcroft-Gault (CG) equation was derived from 236 hospital in-patients in Canada (4 
% women, ethnicity not stated) with measured creatinine clearance (CrCl) as the reference 
procedure (mean CrCl 73 ml/min) (15). 
Neither of these formulae nor the ethnicity factor of 1.212 established for African Americans 
have been evaluated in African or non American black populations before. The applicability 
of these equations and the factor for ethnicity to black South Africans is therefore unknown. 
5The aim of this study was to examine the applicability of the 4-v MDRD and CG equations 
for estimating GFR in black South Africans against measured GFR and to evaluate whether 
the ethnicity factor established for African Americans is appropriate for black South 
Africans.
6Methods
Participants
This study was a prospective study of patients seen at Chris Hani Baragwanath Hospital in 
2006. Participants were recruited after being screened and counseled by their clinicians. 
These included participants with risk factors for developing CKD such as hypertension, 
diabetes mellitus and HIV as well as patients with established CKD. All participants were 
older than 18 years. Exclusion criteria were pregnancy, acute kidney injury and oedema. 100 
black South Africans with varying degrees of renal function were enrolled in the study. 
Informed consent was obtained from all participants after being educated with regard to the
potential benefits, risks and the study procedures. The study was approved by the Human 
Research Ethics Committee of the University of the Witwatersrand.
Test Methods
Age (years), standing height (centimeters), weight (kilogram) and gender were recorded for 
all participants. A 5 ml blood sample was collected for serum creatinine measurement prior to 
GFR measurement. Serum creatinine was measured using an alkaline picrate rate-blanked 
compensated kinetic assay (Roche Modular analyzer, Roche Diagnostics, Mannheim, 
Germany) with calibration traceable to IDMS. To assess possible calibration differences a 
calibration panel obtained from the Cleveland Clinic Foundation was used. This calibration 
panel consisted of 40 serum samples, with values assigned by a Roche enzymatic assay 
(Creatinine Plus, Roche Diagnostics) measured at the Cleveland Clinic Laboratories. This 
assay has been independently validated to be traceable to IDMS (19). 
7GFR Measurements
In this study 51Cr-EDTA plasma clearance was used as a reference method for measuring 
GFR. GFR was measured according to guidelines adopted by the British Nuclear Medicine 
Society (20). GFR was calculated with the slope intercept method (21) corrected with the 
Brochner-Mortensen equation (22) and normalized to body surface area (BSA) using the 
DuBois method (BSA (m2) = (71.84 weight (kg)0.425 * height (cm)0.725) / 10 000) (23). This 
measurement will be referred to as measured GFR (mGFR). 
(For a detailed description of the GFR measurements see Supplemental File: GFR 
measurement protocol)
GFR Estimations
GFR was estimated using the following equations: 
1. The re-expressed 4-v MDRD equation (18, 25):
eGFR (mL/min/1.73m2) = 175 * (S-Cr (μmol/L) / 88.4) -1.154 * (age) -0.203 * (0.742 if 
female) * (1.212 if African American)
To assess the validity of the African American term in the black South African population 
GFR was estimated both with and without the African American ethnicity factor. 
2. The Cockcroft-Gault equation (15) normalized to 1.73 m2:
eGFR (mL/min/1.73m2) = [(140 – age) * Weight (kg) * (0.85 if female) * 1.73 (m2)] / [S-
Cr (μmol/L) * 0.814 * BSA (m2)]
8The CG equation was normalized to 1.73m2 to allow comparison with the 4-v MDRD 
equation and measured GFR. This is in keeping with most studies but is unlikely to reflect 
standard clinical practice (24). As the CG equation was developed with CrCl as the reference 
procedure and a creatinine assay not traceable to current IDMS values, bias is to be expected 
for the CG equation. To minimize this bias a correction factor for the CG equation was 
established. This correction factor was determined from the dataset of 100 patients by 
minimizing the sum of the squared residuals (the difference between eGFR and mGFR).
Statistical Methods
Statistical analysis was conducted using Analyse-it for Microsoft Excel. The Shapiro-Wilk 
test was used to test for normality. Continuous data variables are expressed as mean ± SD if 
parametric and median (IQR) if non parametric. The performance of the 4-v MDRD 
equation, both with and without the ethnicity factor and the Cockcroft-Gault equation 
normalized to 1.73m2 were all assessed relative to that of mGFR by use of: (1) Spearman 
correlation coefficient, (2) weighted Deming regression analysis, (3) median percentage 
difference between estimated and measured GFR (percentage bias) and (4) proportion of 
eGFR within 30% of mGFR (P30). Weighted Deming regression analysis was used to take 
into account random error in both measured GFR and serum creatinine measurement (25). 
9Results
Participants
Between August 2006 and November 2006, 100 black South Africans, 51 males and 49 
females, were enrolled in the study. All participants were inpatients at the Chris Hani 
Baragwanath hospital or were being followed up at the renal unit outpatient department at the 
hospital. The study population had a median age of 47 (26), with an age range between 18 
years and 86 years. Median weight was 67 (15) kg, and ranged between 46 and 119 kg. 
Participants included suffered from a wide range of different diseases. The most common of 
which included hypertension (n = 36), diabetes mellitus (n = 25) and HIV (n = 20). Other 
diagnoses included renal calculi, deep venous thrombosis, meningitis, multiple myeloma, 
nephrotic syndrome and epilepsy. Participants being worked up for possible kidney donation 
were also included (n = 7). The median mGFR was 61.7 (53.9) mL/min/1.73m2 with a range 
between 3 and 132 mL/min/1.73m2.  (See Supplemental Data Table 1)  
Test results
Creatinine Calibration
Evaluation of S-Cr calibration was based on 39 observations as one of the samples with a 
difference between the assigned value and the measured value more than 3 SDs from the 
mean difference was excluded from the analysis. The measurements were done in triplicate in 
three separate runs with measured S-Cr values ranging from 44 µmol/L to 398 µmol/L. The 
correlation between the Cleveland Clinic Foundation (CCF) assigned values and the South 
African measured values was high (R2 = 0.999). Deming regression analysis was used to 
calculate the slope, 0.964 (95% CI 0.952 to 0.975) and intercept, 0.039 (95% CI 0.010 to 
0.068) of the regression equation, with y = CCF assigned values and x = SA measured values. 
Because of this small but significant regression slope, measured S-Cr (SA) values were 
10
standardized to CCF values. The resulting equation to standardize S-Cr (SA) was: 
Standardized S-Cr = 0.039 + 0.964 * S-Cr (SA). Standardized S-Cr values were used in all 
calculations.
Comparison of measured GFR to the 4-variable MDRD equation
The Spearman correlation coefficient between mGFR and the 4-v MDRD equation was 0.90 
(95% CI 0.85-0.93). Weighted Deming regression analysis showed a significant proportional 
bias 1.24 (95% CI 1.09 to1.38, p = 0.001) but no significant constant bias 0.24 (95% CI -5.91 
to 5.43, p = 0.93) when the established ethnicity factor of 1.212 was used. Without the 
ethnicity factor weighted Deming regression analysis showed no significant proportional bias 
1.02 (95% CI 0.90 to 1.14, p = 0.73) or constant bias 0.02 (95% CI -4.61 to 4.65, p = 0.99). 
The percentage bias (median percentage difference between eGFR and mGFR) for the 4-v 
MDRD equation with the established ethnicity factor of 1.212 was 27 %. Without the 
ethnicity factor, percentage bias was 5 %. With the ethnicity factor of 1.212 P30 for the 4-v 
MDRD equation was 52 % compared to 74 % without the ethnicity factor. (Fig. 1)
11
Fig 1: Difference Plot: 4-v MDRD equation and measured GFR
(A) Difference Plot, With African American Ethnicity Factor (1.212)
(B) Difference Plot, Without African American Ethnicity Factor
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Comparison of measured GFR to the Cockcroft-Gault equation
The Spearman correlation coefficient between mGFR and CG normalized to 1.73m2 was 0.89 
(95% CI 0.85 to 0.93). Weighted Deming regression analysis comparing the CG equation to 
mGFR showed a significant proportional bias 1.13 (95% CI 1.03 to 1.23, p = 0.01) but no 
significant constant bias 2.38 (95% CI -1.37 to 6.13, p = 0.21). Percentage bias for the CG 
equation was 19 %. P30 for the CG equation was 58 %. The factor calculated to minimize bias 
of the CG equation in this dataset was 0.82 (95% CI 0.78 to 0.85). Correcting the CG 
equation for bias, eGFR (mL/min/1.73m2) = 0.82 * CG (mL/min/1.73m2), improved P30 to 71 
%. 
Performance of equations at different stages of renal disease
For each of the eGFR equations the dataset was split into three groups: eGFR < 30 
mL/min/1.73m2, eGFR 30-60 mL/min/1.73m2 and eGFR > 60 mL/min/1.73m2. In each of 
these groups median difference between eGFR and mGFR (bias), percentage bias, inter 
quartile range of the difference between eGFR and mGFR’s (IQR) and root mean squared 
error (RMSE)were calculated. For each of the equations, bias, IQR and RMSE increased at 
higher levels of eGFR (Table 1).
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Discussion
CKD is increasingly recognized as a global public health problem (1). The high prevalence of 
hypertension, diabetes mellitus and HIV in sub-Saharan Africa has resulted in a high risk for 
CKD (2). The early detection of CKD using simple laboratory tests and GFR prediction 
equations, such as the CG and 4-v MDRD equation is important for the prevention of long 
term complications.  
Neither the CG nor the 4-v MDRD equation has previously been validated in Africa. The 4-v 
MDRD equation has also not been validated in a black population with a different body 
habitus to that of the African Americans. Our results show that both the CG, after correcting 
for bias, and the 4-v MDRD, without the ethnicity factor established for African Americans, 
can be used in black South Africans for estimating GFR. 
Many recent articles have underscored the importance of creatinine standardization (17). For 
this study we used an alkaline picrate rate-blanked compensated kinetic assay (Roche 
Diagnostics) with calibration traceable to IDMS. In a study by Miller et al this method 
showed minimal bias compared to an IDMS value (26). In this study possible calibration 
differences were also assessed and corrected for by using a calibration panel with values 
assigned by the Roche enzymatic assay (Cleveland Clinic Foundation). As the S-Cr results 
were traceable to IDMS the re-expressed 4-v MDRD equation (14) was used. 
The correlation coefficient for the 4-v MDRD equation was similar to studies done in other 
population groups (27-29). The 4-v MDRD equation using the ethnicity factor of 1.212 as 
suggested for African Americans overestimated mGFR in black South Africans. Without the 
ethnicity factor, thus using the same equation as established for Caucasians in the MDRD 
15
study, median overestimation was minimal and there was no significant proportional bias. 
Accuracy within 30 % of mGFR, 52 % with the ethnicity factor of 1.212 and 74 % without 
the ethnicity factor also improved. 
Goldwasser et al showed that African Americans have higher renal creatinine excretion per 
kilogram body weight than Caucasians and concluded that this may be related to differences 
in body composition, muscle metabolism, or diet (30). Lewis et al showed higher serum 
creatinine levels and urinary creatinine excretion rates for a given GFR in African Americans 
compared with non-African Americans (31).  This may not be true for black South Africans 
as the two populations have different origins (32). 
Creatinine generation is determined primarily by muscle mass and dietary intake (6).  
Differences in the ethnicity factor established for African Americans and black South 
Africans may be attributed to differences in muscle mass and body composition as well as 
differences in diet. Various studies have shown that West African athletes have less body fat 
and thicker thighs than Caucasians and this difference is even more striking between East and 
West Africans (33). Mean weight and body surface area for the MDRD study population was 
79.6 ± 16.8 kg and 1.91 ± 0.23 m2 respectively (16). Mean weight and body surface area for 
the MDRD African American study population were 84.1 kg and 1.96m2 respectively (31). 
Mean weight and BSA for the African-American Study of Kidney disease and hypertension 
(AASK) was 90.2 kg and 2.02 m2 respectively (31). As compared to our study which had a 
mean weight and mean BSA of 69.5 ± 13.8 kg and 1.76 ± 0.17 m2 respectively. Differences 
in dietary intake are difficult to quantify it is possible that black South Africans consume less 
creatinine generating food than African Americans due to poorer socioeconomic 
circumstances (34).
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The CG equation is still commonly used for estimating creatinine clearance as an indicator of 
GFR and was therefore included in the analysis. The correlation coefficient for the CG 
equation was similar to studies done in other population groups (27, 28). The positive bias 
observed for the CG equation may be attributed to the CG equation being established using 
creatinine clearance as a reference procedure which overestimates GFR due to the tubular 
secretion of creatinine (6). It may also be attributed to calibration biases between creatinine 
measurement for the original Cockcroft-Gault study and our present study as well as the CG 
equation being established in a different population group relative to our study. 
The study population included 20 patients who were known to be infected with HIV. In South 
Africa the Nelson Mandela/Human Sciences Research Council survey estimated the 
prevalence of HIV in the adult population (aged 15 and 49 years old) to be 15.6% (35). 
Chronic kidney disease (CKD) is increasingly being recognized as an important complication 
of HIV Infection (36) and the estimation of GFR in this population group is therefore 
important. Further studies are needed to evaluate the performance of the 4-v MDRD equation 
in patients infected with HIV.
Limitations of the study were as follows: 1) The relative small sample size of the study.  2) 
The study was conducted at only one geographical site which does not adequately represent 
all population groups in South Africa. Further studies for these population groups are needed. 
3) The characteristics of the study population differed from that of the MDRD study 
population. The study population included hospitalized patients and participants who were 
known to be infected with HIV. In these participants creatinine production may differ and 
they may have reduced creatinine excretion compared to the MDRD study population which 
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consisted out of outpatients with CKD who were otherwise healthy. 4) In this study plasma 
sampling was done at 2 and 4 hours for patients with eGFR > 30mL/min/1.73m2 and at 3 and 
5 hours for patients with eGFR < 30 mL/min/1.73m2. Using the renal clearance of 51Cr-
EDTA as a reference procedure Brochner-Mortensen et al showed that in patients with 
advanced chronic kidney disease (GFR range: 3 – 13 mL/min) plasma sampling done at 4 and 
24 hours after injection is more reliable (0.5 mL/min  0.5 mL/min) than plasma sampling 
done between 3 and 5 hours (3.7 mL/min  2.2 mL/min) (37). However in the SA context 
delayed plasma sampling may have resulted in patients being lost to follow up. 6) The 
Cleveland Clinic calibration panel and participant samples were run at different times. A 
residual calibration error is therefore still possible. 
In summary, our study confirms that both the 4-v MDRD equation, without the ethnicity 
factor of 1.212, and the Cockcroft-Gault equation, after correcting for bias, can be used for 
estimating GFR in black South Africans. 
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Appendix I: GFR Measurement Protocol
In this study 51Cr-EDTA plasma clearance was used as a reference method for measuring 
GFR. A close correlation between plasma clearance of 51Cr-EDTA and inulin clearance has 
been demonstrated (1, 2).  
GFR was measured according to guidelines adopted by the British Nuclear Medicine Society 
(3). 3.7 MBq 51Cr-EDTA (Amersham, UK) was injected intravenously in an antecubital vein 
and the line flushed with 10 ml 0.9 % saline. Blood samples were then collected from the 
contralateral arm at 120 and 240 minutes post injection for patients with eGFR > 30 
mL/min/1.73m2 and at 180 and 300 minutes post injection for patients with eGFR < 30 
mL/min/1.73m2. The exact time of sample collection was noted and used in the calculation of 
GFR. After centrifugation (3000 g for 10 min) the radioactivity in all plasma samples was 
counted on a gamma counter (Cobra, Auto-Gamma counter, Packard Biosciences) for 5 min 
with appropriate standards and blanks. All counting was done in triplicate. GFR was then
calculated with the slope intercept method (2) corrected with the Brochner-Mortensen 
equation (4). GFR was normalized to body surface area (BSA) using the DuBois method
(BSA (m2) = (71.84 weight (kg)0.425 * height (cm)0.725) / 10 000) (5). This measurement will 
be referred to as measured GFR (mGFR).
51Cr-EDTA plasma clearance using the slope intercept method corrected with the Brochner-
Mortensen equation provides a good compromise between accuracy and reliability on the one 
hand and simplicity on the other hand (3). This method has been independently validated by 
Fleming et al (6). Picciotto et al showed that 51Cr-EDTA total plasma clearance can be 
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accurately calculated using the slope-intercept method corrected with the Brochner-
Mortensen equation for clearance values as low as 10 mL/min/1.73m2 (7). 
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Appendix II: Supplemental Table
Table: Participant Characteristics
Median (IQR)
Age, years 47 (26)
Males 40 (27)
Females 49 (25)
Weight, kg 67 (15)
Males 67 (16)
Females 67 (15)
Height, cm 168 (12)
Males 171 (7)
Females 161 (12)
Body surface area, m2 1.75 (0.19)
Males 1.79 (0.20)
Females 1.69 (0.17)
Standardized S-Cr, μmol/L 97 (91)
Males 102 (103)
Females 80 (84)
Measured GFR, mL/min/1.73m2 62 (49)
Males 62 (58)
Females 61 (48)
26
Appendix III: Supplemental Figure
Supplemental Fig: Weighted Deming Regression Analysis between 4-v MDRD equation and measured GFR: 
(A) Weighted Deming regression analysis , With African American Ethnicity Factor: 1.212
(B) Weighted Deming regression analysis, Without African American Ethnicity Factor
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Appendix IV: Analysis of Participants known to be HIV positive
A limitation to this study is that the study population included hospitalized patients and 
participants who were known to be infected with HIV. In these participants creatinine 
production may potentially differ and they may have reduced creatinine excretion compared 
to the MDRD study population which consisted out of outpatients with CKD who were 
otherwise healthy. 
Analysis of this subset of participants is therefore of importance. The study population 
included 20 patients who were known to be HIV positive.  
Participants known to be HIV positive
This study population had a median age of 35 (10), with an age range between 27 years and 
54 years. Median weight was 60 (9) kg, and ranged between 49 and 92 kg. The Mann-
Whitney test showed a significant difference in weight in participants known to be infected 
with HIV and the remaining participants, 68 (16) kg (P < 0.05).  The Mann Whitney test did 
not show a significant difference between median S-Cr results for the group known to be HIV 
positive 106 (106) μmol/L and the remaining participants 93 (87) μmol/L (P=0.68). The 
median mGFR was 66 (57) mL/min/1.73m2 with a range between 11 and 103 
mL/min/1.73m2. The Mann Whitney test did not show any significant difference between 
mGFR for this group known to be HIV positive and the remaining participants (mGFR = 60 
(48) mL/min/1.73m2) (P=0.64). 
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Comparison of measured GFR to the 4-variable MDRD equation in subset of 
participants known to be HIV positive
The Spearman correlation coefficient between mGFR and the 4-v MDRD equation was 0.87 
(95% CI 0.69-0.95). Proportional bias and constant bias, calculated using weighted Deming 
Regression analysis, was 1.23 (95% CI 0.98 to1.49, p = 0.07) and -1.35 (95% CI 11.28 to 
8.58, p = 0.78) respectively when the established ethnicity factor of 1.212 was used. Without 
the ethnicity factor proportional bias was 1.01 (95% CI 0.82 to 1.20, p = 0.91) and constant 
bias was -0.49 (95% CI -7.11 to 6.12, p = 0.88). The percentage bias (median percentage 
difference between eGFR and mGFR) for the 4-v MDRD equation with the established 
ethnicity factor of 1.212 in this subset of patients was 22 %. Without the ethnicity factor, 
median percentage bias was 1 %. With the ethnicity factor of 1.212 P30 for the 4-v MDRD 
equation was 60 % compared to 70 % without the ethnicity factor.
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Fig 1: Difference Plot: 4-v MDRD equation and measured GFR (Participants known to be HIV positive)
(A) Difference Plot, With African American Ethnicity Factor (1.212)
(B) Difference Plot, Without African American Ethnicity Factor
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Discussion
Stohr et al reported, as part of the Development of Antiretroviral Therapy in Africa (DART) 
study, that moderate renal impairment in HIV infected adults in Africa, was more frequently 
identified using Cockcroft-Gault eGFR than 4-v MDRD eGFR (with the established African 
American ethnicity factor) (1). However no “gold standard” GFR measurement was used. A 
potential reason for this is that using the African American ethnicity factor in the African 
population results in an overestimation of true GFR. In this study the percentage bias (median 
percentage difference between eGFR and mGFR) for the 4-v MDRD equation with the 
established ethnicity factor of 1.212 for all participants was 27 %. Without the ethnicity 
factor, percentage bias was 5 %. The percentage bias (median percentage difference between 
eGFR and mGFR) for the 4-v MDRD equation with the established ethnicity factor of 1.212 
in the subset of patients known to be infected with HIV was 22 %. Without the ethnicity 
factor, median percentage bias was 1 %.
Barraclough et al recently reported in a small (n=27) study, using the renal clearance of Tc-
99m Pentetate as GFR measurement, that the 4-v MDRD equation performed with a level of 
accuracy and precision sufficient for clinical decision making (2). Ravasi et al reported that 
the 4-v MDRD equation showed a satisfactory correlation with creatinine clearance (3). 
Further studies evaluating GFR estimation equations in patients with HIV are necessary. 
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Appendix V: Limitations of Glomerular Filtration Rate 
estimation equations
Limitations of eGFR equations are well described and various articles caution against the 
indiscriminate use of eGFR equations. 
Currently the 4-v MDRD equation is not recommended for drug dosing adjustment. 
Creatinine calibration to ID-MS reference methods results in lowering of creatinine results 
compared to creatinine measurements performed to establish drug dosing adjustment 
guidelines (1). Current drug dosing guidelines use the Cockcroft-Gault equation to estimate 
creatinine clearance and these estimation equations have not been adjusted for use with ID-
MS traceable creatinine measurements (1). It is also important to note that the Cockcroft 
Gault equation estimates creatinine clearance (2) and the 4-v MDRD equation estimates GFR 
(3).  In a recent study Roblin et al showed significant differences in estimates obtained by the 
Cockcroft-Gault equation and 4-v MDRD equation and concludes that the4-v MDRD 
equation cannot replace the Cockcroft Gault equation for drug dose adjustment (4).. Kallner 
et al caution that the 4-v MDRD equation does not include any body size marker and is thus a 
dangerous marker for guiding drug administration (5).
Use of the 4-v MDRD equation is not recommended for acutely ill patients. Poggie et al 
reported accuracy within 50 % of measured GFR to be only 49 % for the 4-v MDRD 
equation in sick patients with renal dysfunction (6). 
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The performance of the 4-v MDRD equation in patients without CKD is unclear (7). Current 
recommendation state that eGFR for these patients should be reported as “> 60 
mL/min/1.73m2” (8). It has also been shown that eGFR present a significant underestimation 
compared to “gold standard” measured GFR in diabetic patients with hyperfiltration (9). 
Little evidence exists validating the 4-v MDRD equation in older people (> 75 years) (7). 
Lamb et al reported that in a group of patients aged 69 – 92 years that the 4-v MDRD 
equation performed reasonably well in this population but that further larger studies are 
needed (10).
Application of 4-v MDRD eGFR may lead to errors in GFR estimation on persons with 
extremes of body size, muscle mass or nutritional status (11, 12).  
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Appendix VI: Glomerular Filtration Rate estimation equations in 
other population groups
The MDRD equation was developed in the United States and included both Caucasian and 
African American participants with chronic kidney disease, for the African American 
population an ethnicity factor was established for use with the MDRD equation (1). The 
validity of the MDRD study in other population groups needs to be evaluated (2). Various 
studies have been done evaluating the MDRD equation in different population groups (Table 
1). Most of these studies found the MDRD equation to be valid, a notable exception being the 
study by Ma et al which established a modified MDRD equation for the Chinese population 
(3). 
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Table 1: Characteristics of some studies in which the MDRD equation has been evaluated
Author Population Participant 
characteristics
Reference GFR 
measurement
Lewis et al. 
2001 (4)
United States -
African Americans
Presumed hypertensive 
nephrosclerosis
125I-iothalamate
clearance
Ma et al.
2006 (3)
Chinese Chronic Kidney Disease 99mTc-DTPA clearance
Imai et al.
2007 (5)
Japanese Chronic Kidney Disease Inulin clearance
Jafar et al.
2005 (6)
Pakistan Age > 40 years Creatinine clearance
Mahajan et al.
2005 (7, 8)
India Renal donors 99mTc-DTPA clearance
Jones et al.
2009 (9)
Australia Patients routinely referred 
for GFR measurement
99mTc-DTPA clearance
Nobrega et al.
2006 (10)
Brasilia Chronic kidney disease Creatinine clearance
Ibrahim et al.
2008 (11)
Egypt Renal donors 99mTc-DTPA clearance
Bostom  et al.
2002 (12)
Germany and 
Austria
Chronic Kidney Disease Iohexol clearance
Van Den Noortgate 
et al. 2002 (13)
Belgium Geriatric (> 70 years) 
hospital inpatients
51Cr-EDTA clearance
Mariat et al. 
2002 (14)
France Renal transplant recipients Inulin clearance
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Estimating Glomerular Filtration Rate in
Black South Africans by Use of the
Modification of Diet in Renal Disease and
Cockcroft-Gault Equations
Hendrick E. van Deventer,1* Jaya A. George,1 Janice E. Paiker,1 Piet J. Becker,2 and Ivor J. Katz3
BACKGROUND: The 4-variable Modification of Diet in
Renal Disease (4-v MDRD) and Cockcroft-Gault
(CG) equations are commonly used for estimating
glomerular filtration rate (GFR); however, neither of
these equations has been validated in an indigenous
African population. The aim of this study was to eval-
uate the performance of the 4-v MDRD and CG equa-
tions for estimating GFR in black South Africans
against measured GFR and to assess the appropriate-
ness for the local population of the ethnicity factor es-
tablished for African Americans in the 4-v MDRD
equation.
METHODS: We enrolled 100 patients in the study.
The plasma clearance of chromium-51–EDTA (51Cr-
EDTA) was used to measure GFR, and serum cre-
atinine was measured using an isotope dilution mass
spectrometry (IDMS) traceable assay. We estimated
GFR using both the reexpressed 4-v MDRD and
CG equations and compared it to measured GFR
using 4 modalities: correlation coefficient, weighted
Deming regression analysis, percentage bias, and pro-
portion of estimated GFR within 30% of measured
GFR (P30).
RESULTS: The Spearman correlation coefficient be-
tween measured and estimated GFR for both equa-
tions was similar (4-v MDRD R2 0.80 and CG R2
0.79). Using the 4-vMDRDequationwith the ethnicity
factor of 1.212 as established for African Americans
resulted in amedian positive bias of 13.1 (95%CI 5.5 to
18.3)mL/min/1.73m2.Without the ethnicity factor, me-
dian bias was 1.9 (95%CI0.8 to 4.5) mL/min/1.73m2.
CONCLUSIONS: The 4-v MDRD equation, without the
ethnicity factor of 1.212, can be used for estimating
GFR in black South Africans.
© 2008 American Association for Clinical Chemistry
Globally, chronic kidney disease (CKD)4 is recognized
as an important public health problem (1 ). In South
Africa, the high prevalence of hypertension, diabetes,
and infection with HIV results in a significant risk for
CKD (2 ); it is therefore important to detect kidney
dysfunction as early as possible in this population.
Current guidelines define CKD as the presence, for 3
or more months, of either kidney damage as defined
by structural or functional abnormalities of the kidney
or a glomerular filtration rate (GFR) 60 mL/min/
1.73 m2 (3, 4 ). GFR, an important component in the
diagnosis of CKD, is also accepted as the best overall
measure of kidney function (3, 5 ). Individuals with de-
creased GFR are at increased risk not only for the
development of end-stage renal failure, but also for
hospitalizations, cardiovascular disease, and other
complications of decreased kidney function (6–10). It
has been shown that early detection, appropriate eval-
uation, and management of CKD improves outcome
(1, 3, 4 ).
GFR can be measured as the renal clearance of ex-
ogenous markers such as inulin, chromium-51–EDTA
(51Cr-EDTA), technetium-labeled diethylene-triamine-
pentacetate (99mTc-DTPA), and iohexol. These exoge-
nous markers are impractical for routine use, how-
ever. Endogenous GFRmarkers include creatinine and
cystatin C. Creatinine is the most commonly used
marker in the clinical laboratory to assess GFR, but it
1 Department of Chemical Pathology and NHLS, University of the Witwatersrand,
Johannesburg, South Africa; 2 Biostatistics Unit, South African Medical Research
Council and School of Therapeutic Sciences, University of the Witwatersrand,
South Africa; 3 Division of Nephrology, Chris Hani Baragwanath Hospital,
University of the Witwatersrand, Johannesburg, South Africa.
* Address correspondence to this author at: Department of Chemical Pathology,
Wits Medical School, 7 York Road, Parktown 2193, South Africa. E-mail
manuel.vandeventer@gmail.com.
Received October 29, 2007; accepted April 7, 2008.
Previously published online at DOI: 10.1373/clinchem.2007.099085
4 Nonstandard abbreviations: CKD, chronic kidney disease; GFR, glomerular
filtration rate; 51Cr-EDTA, chromium-51–EDTA; eGFR, estimated GFR; S-Cr,
serum creatinine; 4-v MDRD, 4-variable Modification of Diet in Renal Disease;
CG, Cockcroft-Gault; IDMS, isotope dilution mass spectrometry; CrCl, creatinine
clearance; BSA, body surface area; mGFR, measured GFR; IQR, interquartile
range.
Clinical Chemistry 54:7
1197–1202 (2008)
General Clinical Chemistry
1197
Appendix VII: Reprint of Article
40
has multiple limitations (11)—for example, it is also
affected by factors such as muscle mass, diet, sex, and
age (12, 13).
To overcome some of these limitations, the Na-
tional Kidney Foundation–Kidney Disease Outcomes
Quality Initiative and Kidney Disease: Improving
Global Outcomes guidelines recommend the estima-
tion of GFR (eGFR) using prediction equations based
on serum creatinine (S-Cr) (3, 4 ). The 2 most com-
monly used prediction equations are the 4-variable
Modification of Diet in Renal Disease (4-v MDRD)
(14) and Cockcroft-Gault (CG) (15) equations. The
MDRD equation was derived in the United States by
analysis of data from 1628 patients (651 women and
195 African-Americans) with known kidney disease
using 125I-iothalamate clearance tomeasureGFR as the
reference procedure (mean GFR 40 mL/min/1.73 m2)
and was based on 6 variables: age, sex, serum creati-
nine, urea, albumin, and ethnicity (16). Subsequently,
a 4-v MDRD equation based on 4 variables—age, sex,
serum creatinine, and ethnicity—was proposed to
simplify its use in the clinical environment (14). An
ethnicity factor of 1.212 was established for African
Americans (14, 16).
Because of variability in serum creatinine assays,
the National Kidney Disease Education Program Lab-
oratory Working Group initiated a creatinine stan-
dardization program with creatinine calibration trace-
able to isotope dilution mass spectrometry (IDMS)
creatinine measurement (17). The 4-v MDRD equa-
tion was reexpressed for use with the IDMS traceable
creatinine measurements (18).
The Cockcroft-Gault equation was derived from
236 hospital inpatients in Canada (4%women, ethnic-
ity not stated) with measured creatinine clearance
(CrCl) as the reference procedure (mean CrCl 73 mL/
min) (15).
Neither of these formulae nor the ethnicity factor
of 1.212 established for African Americans has yet been
evaluated in African or non-American black popula-
tions. The applicability of these equations and the fac-
tor for ethnicity to black South Africans is therefore
unknown. The aim of this study was to examine the
applicability of the 4-v MDRD and CG equations for
estimating GFR in black South Africans against mea-
sured GFR and to evaluate whether the ethnicity factor
established for African Americans is appropriate for
black South Africans.
Materials andMethods
PARTICIPANTS
We conducted a prospective study of patients seen at
Chris Hani Baragwanath Hospital in 2006. Partici-
pants, who were recruited after being screened and
counseled by their clinicians, were older than 18 years
and had established CKD or risk factors for developing
CKD, such as hypertension, diabetes, and HIV. Exclu-
sion criteria were pregnancy, acute kidney injury, and
edema. We enrolled 100 black South Africans with
varying degrees of renal function. All participants gave
informed consent after being educated with regard to
potential benefits, risks, and study procedures. The
study was approved by the Human Research Ethics
Committee of the University of the Witwatersrand.
TEST METHODS
Age (years), standing height (centimeters), weight
(kilograms), and sex were recorded for all participants.
Before GFR measurement, we collected a 5-mL blood
sample for serum creatinine measurement using an al-
kaline picrate rate-blanked compensated kinetic assay
(Roche Modular analyzer; Roche Diagnostics) with
calibration traceable to IDMS. To assess possible cali-
bration differences, we used a calibration panel of 40
serum samples (Cleveland Clinic Foundation), with
values assigned by a Roche enzymatic assay (Creatinine
Plus; Roche Diagnostics), that has been independently
validated as traceable to IDMS (19).
GFR MEASUREMENTS
We used 51Cr-EDTA plasma clearance as a reference
method for measuring GFR. GFR was measured ac-
cording to guidelines adopted by the British Nuclear
Medicine Society (20) and calculated with the slope
intercept method (21), corrected with the Brochner-
Mortensen equation (22), and normalized to body
surface area (BSA) using the DuBois method: BSA
(m2) [71.84 weight (kg)0.425 height (cm)0.725]/
10 000 (23). This value is referred to as measured GFR
(mGFR). (For a detailed description of the GFR mea-
surements, see the Data Supplement that accompanies
the online version of this article at www.clinchem.
org/content/vol54/issue7.)
GFR ESTIMATIONS
GFR was estimated using the following equations:
• reexpressed 4-v MDRD equation (18, 24): eGFR
(mL/min/1.73 m2)  175  [S-Cr (mol/L)/
88.4]1.154 age (years)0.203 (0.742 if female)
(1.212 if African American)
• Cockcroft-Gault equation (15) normalized to 1.73 m2:
eGFR (mL/min/1.73 m2) [(140 age in years)
weight (kg)  (0.85 if female)  1.73 (m2)]/[S-Cr
(mol/L) 0.814 BSA (m2)]
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To assess the validity of the 4-v MDRD equation with
the African American factor in the black South African
population, GFR was estimated both with and without
this factor. TheCGequationwas normalized to 1.73m2
to allow comparison with the 4-vMDRD equation and
measuredGFR. This is in keepingwithmost studies but
is unlikely to reflect standard clinical practice (25). Be-
cause the CG equation was developed with CrCl as the
reference procedure and a creatinine assay not trace-
able to current IDMS values, bias is to be expected for
the CG equation. Tominimize this bias, we established
a correction factor for the CG equation, determined
from the dataset of 100 patients byminimizing the sum
of the squared residuals (the difference between eGFR
and mGFR).
STATISTICAL METHODS
Statistical analysis was conducted using Analyze-it for
Microsoft Excel. We used the Shapiro-Wilk test to test
for normality. Continuous data variables are expressed
as mean (SD) if parametric and median [interquartile
range (IQR)] if nonparametric. We assessed the per-
formance of the 4-v MDRD equation, both with and
without the ethnicity factor, and the Cockcroft-Gault
equation normalized to 1.73 m2 relative to that of
mGFR by use of Spearman correlation coefficient,
weighted Deming regression analysis, median percent-
age difference between estimated and measured GFR
(percentage bias), and proportion of eGFRwithin 30%
of mGFR (P30). We used weighted Deming regression
analysis to take into account random error in both
measured GFR and serum creatinine measurement
(24).
Results
PARTICIPANTS
Between August 2006 and November 2006, 100 black
South Africans (51 men and 49 women) were enrolled
in the study. All participants were inpatients at the
Chris Hani Baragwanath hospital or were being fol-
lowed up at the renal unit outpatient department at the
hospital. The study population had amedian (IQR) age
of 47 (26) years, range 18–86 years. Participants suf-
fered from a wide range of different diseases, the most
common of which included hypertension (n  36),
diabetes (n 25), and HIV (n 20). Other diagnoses
included renal calculi, deep venous thrombosis, men-
ingitis, multiple myeloma, nephrotic syndrome, and
epilepsy. Participants being worked up for possible
kidney donation were also included (n  7). The me-
dian mGFR was 61.5 (49.6) mL/min/1.73 m2, range
3–132 mL/min/1.73 m2. (See Supplemental Table 1.)
CREATININE CALIBRATION
Evaluation of S-Cr calibration was based on 39 obser-
vations, after excluding one of the samples with a dif-
ference between the assigned value and the measured
value of 3 SDs from the mean difference. The mea-
surements were done in triplicate in 3 separate runs,
with measured S-Cr values ranging from 44 to 398
mol/L. The correlation between the Cleveland Clinic
Foundation (CCF) assigned values and the South Afri-
can (SA)measured values was high (R2 0.999). Dem-
ing regression analysis was used to calculate the slope,
0.964 (95% CI 0.952 to 0.975), and intercept, 0.039
(95% CI 0.010 to 0.068), of the regression equation,
with y  CCF-assigned values and x  SA-measured
values. Because of this small but significant regression
slope, measured S-Cr (SA) values were standardized to
CCF values with the following equation: standardized
S-Cr  0.039  [0.964  S-Cr (SA)]. Standardized
S-Cr values were used in all calculations.
COMPARISON OF MEASURED GFR TO THE 4-v MDRD EQUATION
The Spearman correlation coefficient between mGFR
and the 4-v MDRD equation was 0.90 (95% CI 0.85 to
0.93). Weighted Deming regression analysis showed
a significant proportional bias of 1.24 (95% CI 1.09 to
1.38, P 0.001) but no significant constant bias [0.24
(95%CI5.91 to 5.43,P 0.93)]when the established
ethnicity factor of 1.212 was used. Without the ethnic-
ity factor, weightedDeming regression analysis showed
no significant proportional bias [1.02 (95% CI 0.90 to
1.14, P 0.73)] or constant bias [0.02 (95% CI4.61
to 4.65, P  0.99)]. The percentage bias (median per-
centage difference between eGFR and mGFR) for the
4-v MDRD equation with the established ethnicity
factor of 1.212 was 27%. Without the ethnicity factor,
percentage bias was 5%. With the ethnicity factor of
1.212, P30 for the 4-vMDRD equation was 52% vs 74%
without the ethnicity factor (Fig. 1).
COMPARISON OF MEASURED GFR TO THE CG EQUATION
The Spearman correlation coefficient between mGFR
and CG normalized to 1.73 m2 was 0.89 (95% CI 0.85
to 0.93). Weighted Deming regression analysis com-
paring the CG equation to mGFR showed a significant
proportional bias of 1.13 (95% CI 1.03 to 1.23, P 
0.01) but no significant constant bias [2.38 (95% CI
1.37 to 6.13, P  0.21)]. Percentage bias for the CG
equation was 19%, and P30 was 58%. The factor calcu-
lated to minimize bias of the CG equation in this data-
set was 0.82 (95% CI 0.78 to 0.85). Correcting the CG
equation for bias, eGFR (mL/min/1.73 m2)  0.82 
CG (mL/min/1.73 m2), improved P30 to 71%.
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PERFORMANCE OF EQUATIONS AT DIFFERENT STAGES
OF RENAL DISEASE
For each of the eGFR equations, the dataset was split
into 3 groups: eGFR 30, 30–60, and 60 mL/min/
1.73m2. In each of these groups, the median difference
between eGFR and mGFR (bias), percentage bias, IQR
of the difference between eGFR and mGFRs, and root
mean squared error were calculated. For each of the
equations, bias, IQR, and root mean squared error in-
creased at higher levels of eGFR (Table 1).
Discussion
CKD is increasingly recognized as a global public
health problem (1 ). The high prevalence of hyperten-
sion, diabetes, and HIV in sub-Saharan Africa has
resulted in a high risk for CKD (2 ). Early detection of
CKD using simple laboratory tests and GFR prediction
equations, such as the CG and 4-v MDRD equations,
is important for the prevention of long-term
complications.
Neither theCGnor the4-vMDRDequationhaspre-
viously beenvalidated inAfrica. The 4-vMDRDequation
has also not been validated in a black population with a
different body habitus than that of African Americans.
Our results show that both the CG (after correcting for
bias) and the 4-v MDRD (without the ethnicity factor
established for African Americans) can be used for esti-
mating GFR in black South Africans.
Many recent articles have underscored the im-
portance of creatinine standardization (17). For this
study, we used an alkaline picrate rate-blanked com-
pensated kinetic assay (Roche Diagnostics) with cali-
bration traceable to IDMS. In a study by Miller et al.
(26), thismethod showedminimal bias comparedwith
an IDMS value.We also assessed and corrected for pos-
sible calibration differences by using a calibration panel
with values assigned by the Roche enzymatic assay
(Cleveland Clinic Foundation). Because the S-Cr re-
sults were traceable to IDMS, we used the reexpressed
4-v MDRD equation (14).
The correlation coefficient for the 4-v MDRD
equation was similar those of studies done in other
population groups (27–29). The 4-v MDRD equation
using the ethnicity factor of 1.212 as suggested for
African Americans overestimated mGFR in black
South Africans. Without the ethnicity factor (thus us-
ing the same equation as established for whites in the
MDRD study), median overestimation was minimal
and there was no significant proportional bias. Accu-
racy within 30% of mGFR was 52% with the ethnicity
factor of 1.212 and 74% without the ethnicity factor.
Goldwasser et al. (30) showed that African Amer-
icans have higher renal creatinine excretion per kilo-
gram body weight than whites and concluded that this
may be related to differences in body composition,
muscle metabolism, or diet. Lewis et al. (31) showed
higher serum creatinine levels and urinary creatinine
excretion rates for a given GFR in African Americans
compared with non-African Americans. This may not
be true for black South Africans, as the 2 populations
have different origins (32).
Creatinine generation is determined primarily by
muscle mass and dietary intake (6 ). Differences in the
ethnicity factor established for African Americans and
black South Africans may be attributed to differences
in muscle mass and body composition as well as differ-
ences in diet. Various studies have shown that West
African athletes have less body fat and thicker thighs
than whites, and this difference is even more striking
between East and West Africans (33). Mean weight
and BSA for the MDRD study population were 79.6
(16.8) kg and 1.91 (0.23) m2, respectively (16); for the
MDRD African American study population, 84.1 kg and
1.96 m2 (31); for the African-American Study of Kidney
disease and hypertension (AASK), 90.2 kg and 2.02 m2
Fig. 1. Difference plot: 4-v MDRD equation and
measured GFR.
(A), With African American ethnicity factor (1.212). (B),
Without African American ethnicity factor.
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(31); and for our study, 69.5 (13.8) kg and 1.76 (0.17)m2.
Differences indietary intakearedifficult toquantify, but it
is likely that black South Africans consume less creati-
nine-generating food than African Americans owing to
poorer socioeconomic circumstances.
The CG equation is still commonly used for esti-
mating creatinine clearance as an indicator of GFR and
was therefore included in the analysis. The correlation
coefficient for the CG equation was similar to those of
studies done in other population groups (27, 28). The
positive bias observed for the CG equation may be at-
tributed to the CG equation being established using
creatinine clearance as a referenceprocedure,whichover-
estimates GFR owing to the tubular secretion of creati-
nine (6). It may also be attributed to calibration biases
between creatinine measurement for the original CG
study and this study, as well as the CG equation being
established in a different population group.
The study population included 20 patients who
were known to be infected with HIV. In South Africa,
the Nelson Mandela/Human Sciences Research
Council survey estimated the prevalence of HIV in the
adult population (15–49 years old) to be 15.6% (34).
Chronic kidney disease is increasingly being recog-
nized as an important complication of HIV infection
(35), and the estimation of GFR in this population
group is therefore important. Further studies are
needed to evaluate the performance of the 4-v MDRD
equation in patients infected with HIV.
Limitations of the study were as follows: a) The
study has a relatively small sample size. b) It was con-
ducted at only one geographical site, which does not
adequately represent all population groups in South
Africa. Further studies for these population groups are
needed. c) The characteristics of the study population
differed from that of theMDRD study population. The
study population included hospitalized patients and
participants who were known to be infected with HIV.
In these participants, creatinine production may differ
and they may have reduced creatinine excretion com-
pared with the MDRD study population, which con-
sisted of outpatients with CKD who were otherwise
healthy. d) In this study, plasma samplingwas done at 2
and 4 h for patients with eGFR 30 mL/min/1.73 m2
Table 1. Performance of equations.a
eGFR n
Median bias,
mL/min/1.73 m2
(95% CI)
Median
percentage
bias, %
IQR,
mL/min/1.73 m2
RMSE,
mL/min/1.73 m2 P30, %
4-v MDRD with ethnicity factor of 1.212
eGFR 30 mL/min/1.73 m2 20 1.7 (1.7 to 4.4) 10.0 7.0 7.2 55
eGFR 30–60 mL/min/1.73 m2 15 8.8 (2.2 to 14.8) 23.8 15.7 18.0 53
eGFR 60 mL/min/1.73 m2 65 20.4 (17.6 to 28) 28.8 28.6 35.1 51
Overall 100 13.1 (5.5 to 18.3) 27.0 25.2 28.5 52
4-v MDRD without ethnicity factor
eGFR 30 mL/min/1.73 m2 21 1.4 (4.0 to 2.2) 6.7 7.0 7.2 67
eGFR 30–60 mL/min/1.73 m2 24 0.4 (6.4 to 5.1) 1.4 11.8 11.8 75
eGFR 60 mL/min/1.73 m2 55 5.1 (0.3 to 17.0) 8.8 26.3 26.8 76
Overall 100 1.9 (0.8 to 4.5) 4.8 16.4 16.6 74
CG
eGFR 30 mL/min/1.73 m2 19 4.1 (0.1 to 6.2) 18.7 6.0 7.3 47
eGFR 30–60 mL/min/1.73 m2 18 6.0 (0.1 to 14.6) 17.4 15.0 16.1 67
eGFR 60 mL/min/1.73 m2 63 14.7 (10.6 to 22.7) 19.2 27.2 30.9 59
Overall 100 9.0 (5.1 to 12.1) 19.1 21.1 22.9 58
CG  0.82
eGFR 30 mL/min/1.73 m2 22 0.7 (3.3 to 3.0) 2.7 6.5 6.5 59
eGFR 30–60 mL/min/1.73 m2 31 2.0 (8.0 to 1.7) 5.0 16.5 16.6 74
eGFR 60 mL/min/1.73 m2 47 1.8 (4.8 to 10.2) 1.9 31.8 31.9 74
Overall 100 0.9 (3.3 to 1.9) 2.4 16.9 16.9 71
a IQR is the difference between estimated and measured GFR. RMSE (root mean squared error) was calculated as the square root of (median difference in estimate
 measured)2  (IQR of the difference)2. P30 is accuracy within 30% of measured GFR.
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and at 3 and 5 h for patients with eGFR30 mL/min/
1.73 m2. Using the renal clearance of 51Cr-EDTA as a
reference procedure, Brochner-Mortensen and Freund
(36) showed that in patients with advanced chronic
kidney disease (GFR 3–13 mL/min) plasma sampling
done at 4 and 24 h after injection is more reliable
[0.5 (0.5) mL/min] than that done between 3 and 5 h
[3.7 (2.2) mL/min]. In the South African context,
however, delayed plasma sampling may have resulted
in patients being lost to follow up. e) The Cleveland
Clinic calibration panel and participant samples were
run at different times. A residual calibration error is
therefore still possible.
In summary, our study confirms that both the 4-v
MDRD equation, without the ethnicity factor of 1.212,
and the Cockcroft-Gault equation, after correcting for
bias, can be used for estimating GFR in black South
Africans.
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Glomerular Filtration Rate Prediction Equations Based on Creatinine and Cystatin C. 
17th IFCC - FESCC European Congress of Clinical Chemistry and Laboratory 
Medicine, Amsterdam, The Netherlands, June 2007
Authors: H.E. van Deventer1, J. George1 and I. Katz2
1Department of Chemical Pathology and NHLS, University of the Witwatersrand, 2Division 
of Nephrology, Chris Hani Baragwanath Hospital, Johannesburg, South Africa
Background: The Modification of Diet in Renal Disease (MDRD) equation is commonly 
used for estimation of glomerular filtration rate (GFR). The aim of this study was to develop 
and evaluate a cystatin C-based prediction equation for estimation of GFR.
Methods: GFR was measured for 100 patients with various degrees of renal function. GFR 
was measured as the plasma clearance of 51Cr-EDTA. Serum creatinine was measured using 
an alkaline picrate assay traceable to isotope dilution mass spectrometry (IDMS). Cystatin C 
was measured using an immunoturbidimetric assay. GFR was estimated using the re-
expressed 4-variable MDRD equation [GFR = 175 *S-Cr (mg/dl)-1.154 *Age-0.203 *0.742 if 
female]. Stepwise multiple linear regression analysis was used to develop a cystatin C-based 
prediction equation.
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Results: Age was statistically significant (P<0.0001) for inclusion in the cystatin C-based 
equation [GFR = 200 *10^Cystatin C*-0.31 *10^Age*-0.0025]. The correlation between estimated and 
measured GFR using the cystatin C-based equation (R2 0.87) and the MDRD equation (R2
0.79) was not significantly different (P=0.1). Proportion of estimated GFR within 30% of 
measured GFR (P30) for the MDRD equation (P30=75%) was not significantly different from 
the cystatin C-based equation (P30=83%) (P=0.2). For patients with GFR > 60 ml/min/1.73m2
precision (standard deviation of the difference between estimated and measured GFR) was 
significantly better for the cystatin C-based equation (13ml/min/1.73m2) than for the MDRD 
equation (19ml/min/1.73m2) (P=0.007). 
Conclusion: The use of cystatin C-based prediction equations as a more precise indicator of 
GFR for those patients with a GFR > 60 ml/min/1.73m2 needs to be further investigated. 
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Estimating Glomerular Filtration Rate in South Africa. American Association for 
Clinical Chemistry annual meeting 2007, San Diego, California, July 2007
Authors: H.E. van Deventer1, J. George1, I. Katz2
1Department of Chemical Pathology and NHLS, University of the Witwatersrand 2Division of 
Nephrology, Chris Hani Baragwanath Hospital, Johannesburg, South Africa
Background: Glomerular filtration rate (GFR) is accepted as the best overall measure of 
renal function. The Cockcroft-Gault and Modification of Diet in Renal Disease (MDRD) 
equations are commonly used for estimating GFR. The MDRD equation includes a correction 
factor of 1.212 for the African American population. 
Objective: The aim of this study was to assess the accuracy of the Cockcroft-Gault and 
MDRD equations in the black South African population and to see whether the correction 
factor of 1.212 is appropriate for the black South African population.
Methods: GFR was measured for 100 patients with various degrees of renal function (Mean 
GFR: 61 ± 32 ml/min/1.73 m2). GFR was measured as the plasma clearance of 51Cr-EDTA. 
Serum creatinine (S-Cr) was measured using an alkaline picrate rate-blanked compensated 
kinetic assay with calibration traceable to isotope dilution mass spectrometry (IDMS) 
creatinine measurement. GFR was estimated using the Cockcroft-Gault equation normalized 
to 1.73m2 and the re-expressed 4-variable MDRD equation [GFR = 175 * S-Cr (mg/dl)-1.154 * 
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Age-0.203 * 0.742 if female]. Estimated GFR was compared to measured GFR using 
correlation coefficient (R2), mean percentage difference between estimated and measured 
GFR (percentage bias) and proportion of estimated GFR within 30% of measured GFR (P30).
Results: The correlation between estimated and measured GFR for the MDRD and 
Cockcroft-Gault equation was the same (R2 0.79). The correlation between estimated and 
measured GFR (MDRD equation) was significantly better for those patients with chronic 
kidney disease (GFR < 60 ml/min/1.73m2) than for those patients with slightly decreased 
renal function (GFR > 60 ml/min/1.73m2), R2 0.78 and R2 0.29 respectively (p<0.001). ROC 
curve analysis for detection of GFR <60ml/min/1.73m2 showed no significant different in the 
area under the curve for the Cockcroft-Gault (0.956) and the MDRD (0.955) equations. 
Percentage bias for the Cockcroft-Gault equation was 15.4%. P30 for the Cockcroft-Gault 
equation was 64%. Correcting the Cockroft-Gault equation for bias (Corrected Cockcroft-
Gault = 0.85 * Cockcroft-Gault) improved P30 to 70%.  Percentage bias for the MDRD 
equation using the correction factor of 1.212 as suggested for the African American 
population was 22.5%. Percentage bias improved to 1.1% when no correction factor was 
used. P30 for the MDRD equation was also significantly better when no correction factor was 
used (P30 = 75%) than when the correction factor of 1.212 was used (P30 = 61%) (p<0.05).
Conclusion: In our study there was no significant difference between the performance of the 
MDRD and Cockcroft-Gault equations. The MDRD equation using the correction factor of 
1.212 as suggested for the African American population overestimates measured GFR in the 
black South African population. This difference may be attributed to a lower proportional 
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muscle mass in the black South African population compared to the African American 
population. The validity of the MDRD equation needs to be further evaluated in different 
population groups.
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A Simplified equation to predict Glomerular Filtration Rate. American Association for 
Clinical Chemistry annual meeting 2008, Washington, District of Columbia, July 2008
Authors: H.E. van Deventer1, J. Paiker1, I. Katz2, J. George1
Background: The 4-variable Modification of Diet in Renal Disease (MDRD) equation is 
commonly used for estimating glomerular filtration rate (GFR) and provides unbiased and 
reasonably accurate estimates of GFR when GFR is <60 ml/min/1.73 m2. However it is 
difficult to calculate without the use of computers, which may not be freely available in 
developing countries. The aim of this study was to develop a simplified equation for 
estimating GFR that can be used at the bedside and to evaluate its performance against the 
MDRD equation.
Methods: GFR was measured in 100 patients using one of the “gold standards”, namely the 
plasma clearance of 51Cr-EDTA. Serum creatinine (S-Cr) was measured using an isotope 
dilution mass spectrometry (ID-MS) traceable assay (Roche Alkaline Picrate). Linear 
regression analysis was used in this cohort to develop the simplified equation: Bedside-GFR 
= 7000/S-Cr (µmol/l) * gender, where gender is 1 for males and 0.75 for females. This 
equation was then compared to the re-expressed MDRD equation (S-Cr assay traceable to ID-
MS) in an independent dataset consisting of 63 304 S-Cr results, of which 20 580 had a 
MDRD-GFR< 60ml/min/1.73m2, collected from patients who attended Johannesburg 
Hospital in 2007. The bedside-GFR equation was evaluated using the following modalities: 
sensitivity and specificity for detecting MDRD-GFR< 60ml/min/1.73m2, correlation 
coefficient, bias and precision.
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Results: Using the entire dataset the sensitivity and specificity of the bedside GFR equation 
to detect MDRD-GFR< 60ml/min/1.73m2 was 94% and 98% respectively. For those patients 
with MDRD-GFR< 60ml/min/1.73m2 the Spearman correlation coefficient between the 
MDRD and bedside-GFR equation was R2 = 0.99 and bias was 2.82 ml/min/1.73m2. In these 
patients 79% of bedside-GFR results were within 5 ml/min/1.73m2, 97% within 
7ml/min/1.73m2 and 100% within 10 ml/min/1.73m2 of MDRD-GFR.
Conclusion: The simplified bedside-GFR equation correlates well with the MDRD equation 
for the estimation of GFR < 60ml/min/1.73m2.

